These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19632767)

  • 1. B-type natriuretic peptide as a marker of subclinical heart injury during mitoxantrone therapy in MS patients--preliminary study.
    Luchowski P; Mitosek-Szewczyk K; Bartosik-Psujek H; Rubaj A; Jankiewicz M; Wojczal J; Szczepańska-Szerej A; Stelmasiak Z
    Clin Neurol Neurosurg; 2009 Oct; 111(8):676-8. PubMed ID: 19632767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
    Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A
    Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mitoxantrone cardiotoxicity in multiple sclerosis patients by dexrazoxane.
    Bernitsas E; Wei W; Mikol DD
    Ann Neurol; 2006 Jan; 59(1):206-9. PubMed ID: 16374818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography.
    Pichon MF; Cvitkovic F; Hacene K; Delaunay J; Lokiec F; Collignon MA; Pecking AP
    In Vivo; 2005; 19(3):567-76. PubMed ID: 15875778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
    Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis.
    Zingler VC; Nabauer M; Jahn K; Gross A; Hohlfeld R; Brandt T; Strupp M
    Eur Neurol; 2005; 54(1):28-33. PubMed ID: 16088176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunosuppressive therapy of multiple sclerosis with mitoxantrone].
    Mauch E; Kornhuber HH
    Fortschr Neurol Psychiatr; 1993 Dec; 61(12):410-7. PubMed ID: 8112704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
    Parekh N; Maisel AS
    Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis: a tissue Doppler echocardiographic analysis.
    Pattoneri P; Sozzi F; Pelà G; Montanari E; Moruzzi P; Borghetti A; Cappellini MD
    Echocardiography; 2009 Apr; 26(4):397-402. PubMed ID: 19017314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer.
    Lafaras C; Mandala E; Saratzis A; Platogiannis D; Barbetakis N; Papoti S; Christopoulou M; Ilonidis G; Bischiniotis T
    Onkologie; 2009 Jul; 32(7):389-92. PubMed ID: 19556815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
    Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
    Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to recommended dosing and monitoring for mitoxantrone in patients with multiple sclerosis: a healthcare claims database study supplemented with medical records--the RETRO study.
    Funch D; Norman H; Wong J; Bennett R; Hillier J; Al-Sabbagh A; Seeger JD
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):448-56. PubMed ID: 20333778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mitoxantrone for the treatment of patients with multiple sclerosis].
    Komori M; Kondo T; Tanaka M
    Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist.
    Watanabe H; Hirayama M; Noda A; Ito M; Atsuta N; Senda J; Kaga T; Yamada A; Katsuno M; Niwa T; Tanaka F; Sobue G
    Neurology; 2009 Feb; 72(7):621-6. PubMed ID: 19221295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac effects of mitoxanthrone therapy in patients with multiple sclerosis.
    Pastuszak Ż; Tomczykiewicz K; Piusińska-Macoch R; Stępień A
    Kardiol Pol; 2016; 74(4):380-4. PubMed ID: 26412472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.